PHASE 1/2 MULTICENTER CLINICAL TRIAL OF TOLERANCE INDUCTION IN LIVING DONOR LIVER TRANSPLANTATION VIA INDUCED T CELLS WITH SUPPRESSING FUNCTIONS

被引:0
|
作者
Uchida, K. [1 ]
Takeda, K. [1 ]
Maehara, Y. [1 ]
Hirota, S. [1 ]
Okumura, K. [1 ]
机构
[1] Juntendo Daigaku, Igakubu Daigakuin, Igaku Kenkyuka, Ctr Immunotherapy & Diag, Bunkyo Ku, Tokyo, Japan
关键词
Transplant; Treg; Tolerance;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
1085
引用
收藏
页码:S253 / S254
页数:2
相关论文
共 50 条
  • [31] Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
    Leventhal, J.
    Galvin, J.
    Mathew, J.
    Gallon, L.
    Belshe, D.
    Gibson, M.
    Ravindra, K.
    Horwitz, M.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 590 - 590
  • [32] Long Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Kidney Transplant Recipients.
    Leventhal, J.
    Galvin, J.
    Mathew, J.
    Gallon, L.
    Belshe, D.
    Gibson, M.
    Ravindra, K.
    Horwitz, M.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 510 - 511
  • [33] Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
    Leventhal, J.
    Mathew, J.
    Galvin, J.
    Gallon, L.
    Belshe, D.
    Ravindra, K.
    Horwitz, M.
    Miller, J.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 291 - 291
  • [34] Ten Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.
    Leventhal, J.
    Galvin, J.
    Gallon, L.
    Stare, D.
    Ravindra, K.
    Horwitz, M.
    Abecassis, M.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 541 - 541
  • [35] Six Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients
    Leventhal, J.
    Abecassis, M.
    Gallon, L.
    Galvin, J.
    Mehta, J.
    Ravindra, K.
    Tollerud, D.
    Elliott, M.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [36] Long-term Follow-up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
    Ildstad, Suzanne
    Leventhal, Joseph
    Galvin, John
    Stare, Dianne
    Kurtenbach, K.
    Ravindra, Kadiyala
    Horwitz, M.
    Abecassis, Michael
    TRANSPLANTATION, 2018, 102 : S394 - S394
  • [37] Long-term Follow-up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients
    Leventhal, Joseph
    Mathew, James
    Galvin, John
    Mehta, Jayesh
    Gibson, Meg
    Belshe, Dianne
    Ravindra, Kadiyala
    Horwitz, Mitch
    Ildstad, Suzanne
    TRANSPLANTATION, 2022, 106 (09) : S43 - S43
  • [38] Induction of donor-specific tolerance in living donor kidney transplant recipients through clinical MIC cell infusion - a phase I study (TOL-1)
    Morath, Christian
    Schmitt, Anita
    Kleist, Christian
    Daniel, Volker
    Opelz, Gerhard
    Suesal, Caner
    Kaelble, Florian
    Sommerer, Claudia
    Wang, Lei
    Hueckelhoven, Angela
    Mehrabi, Arianeb
    Merle, Uta
    da Silva, Luiza Pego
    Mueller-Tidow, Carsten
    Zeier, Martin
    Schaier, Matthias
    Schmitt, Michael
    Terness, Peter
    BONE MARROW TRANSPLANTATION, 2018, 53 : 229 - 230
  • [39] Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation
    Sato, Y
    Ichida, T
    Watanabe, H
    Yamamoto, S
    Abo, T
    Hatakeyama, K
    HEPATO-GASTROENTEROLOGY, 2003, 50 (54) : 2161 - 2165
  • [40] Sirolimus Prolonged Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria; Outcome of a Multicenter Prospective Randomized Control Phase II Trial
    Lee, K. -W
    Yoon, K. C.
    Hong, S. K.
    Kim, S. -H.
    Yi, N. -J
    Park, S. -J
    Han, S. -S
    Suh, K. -S
    TRANSPLANTATION, 2017, 101 (05) : 17 - 17